BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
The RAS family of proteins is amongst the most highly mutated in human cancers and has so far eluded drug therapy. Currently, much effort is being made to discover mutant RAS inhibitors and in vitro screening for RAS-binding drugs must be followed by cell-based assays. Here, we have developed a robu...
Հիմնական հեղինակներ: | Bery, N, Cruz-Migoni, A, Bataille, C, Quevedo, C, Tulmin, H, Miller, A, Russell, A, Phillips, S, Carr, S, Rabbitts, T |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
eLife Sciences Publications
2018
|
Նմանատիպ նյութեր
-
BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
: Nicolas Bery, և այլն
Հրապարակվել է: (2018-07-01) -
Correction: BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
: Nicolas Bery, և այլն
Հրապարակվել է: (2018-08-01) -
Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment
: Quevedo, C, և այլն
Հրապարակվել է: (2018) -
Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds
: Cruz-Migoni, A, և այլն
Հրապարակվել է: (2019) -
Bioluminescence Resonance Energy Transfer 2 (BRET2)‐based RAS biosensors to characterize RAS inhibitors
: Bery, N, և այլն
Հրապարակվել է: (2019)